Dr. Yaffe presented a keynote at the 13th Clinical Trials on Alzheimer’s Disease Conference

“Implementing the lessons of epidemiology”
Kristine Yaffe, MD
Scola Endowed Chair and Vice Chair, Professor of Psychiatry, Neurology and Epidemiology, University of California at San Francisco, San Francisco, California – USA

Dr. Kristine Yaffe is the Scola Endowed Chair and Vice Chair, Professor of Psychiatry, Neurology, and Epidemiology, and Director of the Center for Population Brain Health at the University of California, San Francisco. She is also the Chief of NeuroPsychiatry and Director of the Memory Evaluation Clinic at the San Francisco Veterans Affairs Medical Center. In her research, clinical work, and mentoring, she has directed her efforts towards improving the care of patients with Alzheimer’s and other dementias. Dr. Yaffe is an internationally recognized expert in the epidemiology of dementia and cognitive aging. She serves as PI of almost a dozen NIH, Department of Defense, Veterans Administration, and foundation grants and is the foremost leader in identifying modifiable risk factors for dementia. Dr. Yaffe was the first to determine that potentially 30% of dementia risk is preventable. With over 500 peer-reviewed articles dedicated to improving population brain health (H-index=141; recognized by Clarivate Analytics as one of the most highly cited researchers in her field), her transformative research, bridging neurology, psychiatry, and epidemiology, has formed the cornerstone for dementia prevention trials worldwide. In recognition of her groundbreaking work, Dr. Yaffe has received multiple honors including the Potamkin Prize for Alzheimer’s Research in 2017 and election to the National Academy of Medicine in 2019.